Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-028150

Director acquired 57,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MALLIK AMEET Director 2023-05-31 Grant or award +57,000 77,500 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MALLIK AMEET Director 2023-05-31 Grant or award · Non-Qualified Stock Option (Right to Buy) +79,500 79,500 D: show line 2 in the form
Loading xslF345X04/form4.xml…